Novel follicular-phase gonadotropin-releasing hormone antagonist stimulation protocol for in vitro fertilization in the poor responder

被引:15
|
作者
Frankfurter, David [1 ]
Dayal, Molina [1 ]
Dubey, Anil [1 ]
Peak, Douglas [1 ]
Gindoff, Paul [1 ]
机构
[1] George Washington Univ, Sch Med, Div Reprod Endocrinol Fertil & IVF, Washington, DC USA
关键词
D O I
10.1016/j.fertnstert.2007.01.022
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Poor responders continue to be vexing in infertility therapy. By using GnRH antagonists before ovarian stimulation, we demonstrate an improvement in oocyte, embryo, and zygote yield in patients with a prior poor response.
引用
收藏
页码:1442 / 1445
页数:4
相关论文
共 50 条
  • [1] Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders
    Nikolettos, N
    Al-Hasani, S
    Felberbaum, R
    Demirel, LC
    Kupker, W
    Montzka, P
    Xia, YX
    Schopper, B
    Sturm, R
    Diedrich, K
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2001, 97 (02): : 202 - 207
  • [2] Use of a luteal estradiol patch and a gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders
    Dragisic, KG
    Davis, OK
    Fasouliotis, SJ
    Rosenwaks, Z
    FERTILITY AND STERILITY, 2005, 84 (04) : 1023 - 1026
  • [3] Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation
    Seng, Shay Way
    Ong, Kee Jiet
    Ledger, W. L.
    WOMENS HEALTH, 2006, 2 (06) : 881 - 888
  • [4] Comparison of luteal estradiol patch and gonadotropin-releasing hormone antagonist suppression protocol before gonadotropin stimulation versus microdose gonadotropin-releasing hormone agonist protocol for patients with a history of poor in vitro fertilization outcomes
    Weitzman, Vanessa N.
    Engmann, Lawrence
    DiLuigi, Andrea
    Maier, Donald
    Nulsen, John
    Benadiva, Claudio
    FERTILITY AND STERILITY, 2009, 92 (01) : 226 - 230
  • [5] Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization
    Kolibianakis, EM
    Zikopoulos, K
    Smitz, J
    Camus, M
    Tournaye, H
    Van Steirteghem, AC
    Devroey, P
    FERTILITY AND STERILITY, 2004, 82 (01) : 223 - 226
  • [6] Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization
    Urbancsek, J
    Witthaus, E
    FERTILITY AND STERILITY, 1996, 65 (05) : 966 - 971
  • [7] Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs
    Orvieto, Raoul
    Kruchkovich, Jenny
    Rabinson, Jacob
    Zohav, Efraim
    Anteby, Eyal Y.
    Meltcer, Simion
    FERTILITY AND STERILITY, 2008, 90 (01) : 228 - 230
  • [8] The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome
    Tannus, Samer
    Weissman, Ariel
    Boaz, Mona
    Horowitz, Eran
    Ravhon, Amir
    Golan, Abraham
    Levran, David
    FERTILITY AND STERILITY, 2013, 99 (03) : 725 - 730
  • [9] Early Follicular Phase Human Chorionic Gonadotropin Addition May Improve the Outcomes of In Vitro Fertilization/Intracytoplasmic Sperm Injection in Patients With "Unpredictable" Poor Response to Gonadotropin-Releasing Hormone Antagonist Protocol
    Zhang, Chunhui
    Wu, Fangrong
    Wu, Zexuan
    Sun, Bolan
    Chen, Cheng
    Qian, Weiping
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [10] A novel "delayed start" protocol with gonadotropin-releasing hormone antagonist improves outcomes in poor responders
    Cakmak, Hakan
    Tran, Nam D.
    Zamah, A. Musa
    Cedars, Marcelle I.
    Rosen, Mitchell P.
    FERTILITY AND STERILITY, 2014, 101 (05) : 1308 - 1314